A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

被引：0
|
作者：
Kentaro Yamazaki
Shuichi Hironaka
Narikazu Boku
Hirofumi Yasui
Akira Fukutomi
Takayuki Yoshino
Yusuke Onozawa
Noriaki Hasuike
Tetsuya Inui
Yuichiro Yamaguchi
Hiroyuki Ono
机构：
[1] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
来源：
International Journal of Clinical Oncology | 2008年 / 13卷
关键词：
Esophageal cancer; Nedaplatin; Vindesine; Docetaxel; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：150 / 155
页数：5
相关论文
共 50 条
  • [1] A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Boku, Narikazu
    Yasui, Hirofumi
    Fukutomi, Akira
    Yoshino, Takayuki
    Onozawa, Yusuke
    Hasuike, Noriaki
    Inui, Tetsuya
    Yamaguchi, Yuichiro
    Ono, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (02) : 150 - 155
  • [2] Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin
    Ryohei Kawabata
    Hiroshi Imamura
    Tomono Kishimoto
    Shinji Kitamura
    Yoshimi Hachino
    Yukako Yasui
    Misako Fujino
    Chika Fujii
    Hiroshi Furukawa
    Esophagus, 2011, 8 : 179 - 185
  • [3] Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin
    Kawabata, Ryohei
    Imamura, Hiroshi
    Kishimoto, Tomono
    Kitamura, Shinji
    Hachino, Yoshimi
    Yasui, Yukako
    Fujino, Misako
    Fujii, Chika
    Furukawa, Hiroshi
    ESOPHAGUS, 2011, 8 (03) : 179 - 185
  • [4] Retrospective Study of Gemcitabine Based Chemotherapy for Unresectable or Recurrent Esophagus Squamous Cell Carcinoma Refractory to First Line Chemotherapy
    Wang, Mei
    Gu, Jun
    Wang, Hai-Xing
    Wu, Mei-Hong
    Li, Yong-Mei
    Wang, Ya-Jie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 4153 - 4156
  • [5] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in patients with metastatic or recurrent esophageal squamous cell carcinoma.
    Hiramoto, Shuji
    Kato, Ken
    Shoji, Hirokazu
    Okita, Natsuko T.
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Efficacy and toxicity of second-line chemotherapy in patients with advanced oesophageal squamous cell carcinoma progressing after a first line of 5-fluorouracil and platinum-based therapy: An AGEO retrospective multicentric study
    Auzolle, C.
    Dubreuil, O.
    Pozet, A.
    Coriat, R.
    Dhooge, M.
    Ducreux, M.
    Mons, M.
    Brieau, B.
    Baumgaertner, I.
    Gornet, J. M.
    Lievre, A.
    Locher, C.
    Mary, F.
    Bonnetain, F.
    Landi, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S438 - S438
  • [7] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
    Hiramoto, Shuji
    Kato, Ken
    Shoji, Hirokazu
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Boku, Narikazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 466 - 472
  • [8] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
    Shuji Hiramoto
    Ken Kato
    Hirokazu Shoji
    Natsuko Okita
    Atsuo Takashima
    Yoshitaka Honma
    Satoru Iwasa
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Narikazu Boku
    International Journal of Clinical Oncology, 2018, 23 : 466 - 472
  • [9] Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
    Takano, M.
    Sugiyama, T.
    Yaegashi, N.
    Sakuma, M.
    Suzuki, M.
    Saga, Y.
    Kuzuya, K.
    Kigawa, J.
    Shimada, M.
    Tsuda, H.
    Moriya, T.
    Yoshizaki, A.
    Kita, T.
    Kikuchi, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) : 937 - 942
  • [10] 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site
    Culine, S
    Ychou, M
    Fabbro, M
    Romieu, G
    Cupissol, D
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1455 - 1457
12345